GB9610341D0 - Formulation for inhalation - Google Patents

Formulation for inhalation

Info

Publication number
GB9610341D0
GB9610341D0 GBGB9610341.1A GB9610341A GB9610341D0 GB 9610341 D0 GB9610341 D0 GB 9610341D0 GB 9610341 A GB9610341 A GB 9610341A GB 9610341 D0 GB9610341 D0 GB 9610341D0
Authority
GB
United Kingdom
Prior art keywords
inhalation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9610341.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Priority to GBGB9610341.1A priority Critical patent/GB9610341D0/en
Publication of GB9610341D0 publication Critical patent/GB9610341D0/en
Priority to AU27838/97A priority patent/AU2783897A/en
Priority to JP09541766A priority patent/JP2000512268A/en
Priority to KR1019980709170A priority patent/KR20000011020A/en
Priority to PCT/GB1997/001309 priority patent/WO1997044012A1/en
Priority to CA002253478A priority patent/CA2253478A1/en
Priority to ARP970102089A priority patent/AR007178A1/en
Priority to ZA9704328A priority patent/ZA974328B/en
Priority to NO985341A priority patent/NO985341L/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
GBGB9610341.1A 1996-05-17 1996-05-17 Formulation for inhalation Pending GB9610341D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation
AU27838/97A AU2783897A (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
JP09541766A JP2000512268A (en) 1996-05-17 1997-05-14 Formulation containing fine particles for inhalation
KR1019980709170A KR20000011020A (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
PCT/GB1997/001309 WO1997044012A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
CA002253478A CA2253478A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
ARP970102089A AR007178A1 (en) 1996-05-17 1997-05-16 FORMULATION CONTAINING MICROPARTICLES, FOR INHALATION
ZA9704328A ZA974328B (en) 1996-05-17 1997-05-19 Formulation comprising microparticles, for inhalation.
NO985341A NO985341L (en) 1996-05-17 1998-11-16 Formulation comprising microparticles for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation

Publications (1)

Publication Number Publication Date
GB9610341D0 true GB9610341D0 (en) 1996-07-24

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9610341.1A Pending GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation

Country Status (9)

Country Link
JP (1) JP2000512268A (en)
KR (1) KR20000011020A (en)
AR (1) AR007178A1 (en)
AU (1) AU2783897A (en)
CA (1) CA2253478A1 (en)
GB (1) GB9610341D0 (en)
NO (1) NO985341L (en)
WO (1) WO1997044012A1 (en)
ZA (1) ZA974328B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
AU758351B2 (en) * 1998-08-25 2003-03-20 Alkermes, Inc. Stable spray-dried protein formulations
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ATE508735T1 (en) 2001-12-19 2011-05-15 Novartis Ag PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
MX9702357A (en) * 1994-09-29 1997-06-28 Andaris Ltd Spray-dried microparticles as therapeutic vehicles.

Also Published As

Publication number Publication date
KR20000011020A (en) 2000-02-25
NO985341D0 (en) 1998-11-16
CA2253478A1 (en) 1997-11-27
JP2000512268A (en) 2000-09-19
WO1997044012A1 (en) 1997-11-27
ZA974328B (en) 1998-05-19
AR007178A1 (en) 1999-10-13
NO985341L (en) 1998-11-16
AU2783897A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
US5797392C1 (en) Inhaler
ZA9878B (en) New formulation for inhalation
GB2318737B (en) Improved inhalers
PL327616A1 (en) Inhaler
HUP9901316A3 (en) Inhaler
GB9726916D0 (en) Nasal formulation
PL340493A1 (en) Inhalation apparatus
GB2312379B (en) Improved inhalers
EP0943327A4 (en) Medicinal composition
GB2323041B (en) Inhalation apparatus
ZA9710601B (en) Novel formulation
HUP0004665A3 (en) Anaesthetic formulation
GB9610341D0 (en) Formulation for inhalation
GB2322804B (en) Inhalation apparatus
AU134061S (en) Inhalation device
GB9704742D0 (en) Respiratory monitor
ZA976592B (en) Formulation
IL126069A0 (en) Components for inhalation devices
GB9404989D0 (en) Lipomimetric formulation
SI1032390T1 (en) Anaesthetic formulation
CA78729S (en) Inhalation device
GB9619750D0 (en) Respirator faceseal
GB9624115D0 (en) Formulations
GB9623990D0 (en) Respiratory monitor
GB9625130D0 (en) Respiratory Monitor